A Cutting-Edge Cancer Treatment Is Under FDA Investigation—for Cancer Risk

CAR-T cell therapy harnesses the immune system to attack blood cancers. Six years after approving the first treatment, the FDA is investigating whether it can give rise to secondary cancers.

from Feed: All Latest https://ift.tt/ZrfD9Oj
via IFTTT

No comments:

Post a Comment

You Can Now Pay to Generate More Sora AI Videos, and I'm Concerned

Sora, OpenAI's short-form AI video generator, has been out for just about a month now, and already, it's helping to spread disinform...